Most Clicked StoriesMore >


EMA to create task force to oversee ISO drug standards enforcement

DIA Global SmartBrief | Feb 26, 2015

A task force that will supervise the implementation of new standards to identify medicinal products created by the International Organization for Standardization is being formed by the European Medicines Agency. The EU ISO IDMP Task Force will be composed of representatives from the EMA, national authorities and members of drug industry trade groups. The EMA is inviting those interested in participating to apply by March 6. The agency intends to implement the new IDMP standards in July 2016. Regulatory Focus (02/23)


Global Forum reports on risk-based monitoring

DIA Global SmartBrief | Feb 24, 2015

Study: Drug-resistant malaria on the verge of spreading into India

DIA Global SmartBrief | Feb 24, 2015

Global Forum reports on risk-based monitoring

DIA Global SmartBrief | Feb 26, 2015

New antibiotic development is slow in U.S., study finds

DIA Global SmartBrief | Feb 24, 2015

MedImmune partners with NIST to research drug-development tools

DIA Global SmartBrief | Feb 24, 2015

Sanofi, Lead Pharma join to develop drugs for autoimmune diseases

DIA Global SmartBrief | Feb 24, 2015

Calif. bill would require drugmakers to disclose pricing process of high-cost meds

DIA Global SmartBrief | Feb 26, 2015

More than 3K bottles of levetiracetam recalled by firm

DIA Global SmartBrief | Feb 26, 2015

Valeant buys Salix on strength of IBS drug's expected FDA approval

DIA Global SmartBrief | Feb 24, 2015


Find DIA Global SmartBrief Issues by Date:



DIA News More >


DIA EuroMeeting 2015

DIA Global SmartBrief | Feb 26, 2015

Global Forum reports on risk-based monitoring

DIA Global SmartBrief | Feb 26, 2015

9th DIA Conference in Japan for Asian New Drug Development

DIA Global SmartBrief | Feb 24, 2015

DIA eRegulatory and Intelligence Annual Conference

DIA Global SmartBrief | Feb 19, 2015

About DIA 2015

DIA Global SmartBrief | Feb 19, 2015




Sign up for DIA Global SmartBrief



Designed specifically for the global drug development professional, the DIA Global SmartBrief is a FREE, twice weekly e-mail newsletter. By providing the latest need-to-know industry news and information, the DIA Global SmartBrief saves you time and keeps you smart. Learn more